Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61P - Specific therapeutic activity of chemical compounds or medicinal preparations › A61P 35 - Antineoplastic agents
Patents for A61P 35 - Antineoplastic agents (221,099)
06/2014
06/11/2014CN102060722B Arsenic compound and preparation method and use thereof
06/11/2014CN101970489B Monoclonal antibodies that bind to hgm-csf and medical compositions comprising same
06/11/2014CN101925356B Agent for enhancing anti-tumor effect comprising oxaliplatin liposome preparation, and anti-tumor agent comprising liposome preparation
06/11/2014CN101918447B Binding molecules to the human OX40 receptor
06/11/2014CN101899471B Recombinant retrovirus vector for simultaneously expressing antigen-specific receptor and exogenous gene, B-lymphocyte modified by using same and application thereof
06/11/2014CN101897981B Method for inhibiting proliferation and inducing apoptosis of cancer cells and use thereof
06/11/2014CN101838202B Total terpenoids of ferula dissecta as well as medical application and preparation method thereof
06/11/2014CN101784550B Cytotoxic agents comprising new tomaymycin derivatives and their therapeutic use
06/11/2014CN101400793B Novel cancer-associated antigen
06/11/2014CN101148474B Human resource vessel endothelium growth factor monoclonal antibody and preparation method thereof
06/10/2014US8748564 Oxytocin receptor agonists
06/10/2014US8748470 Methods for treating ovarian cancer by inhibiting fatty acid binding proteins
06/10/2014US8748440 Quinazolinone modulators of nuclear receptors
06/10/2014US8748388 Antitumoral compounds
06/10/2014US8747891 Ceramide anionic liposome compositions
06/10/2014US8747857 Calicheamicin derivative-carrier conjugates
06/10/2014US8747837 Oncolytic vaccinia virus combination cancer therapy
06/10/2014CA2663116C Inhibitors of bruton's tyrosine kinase
06/10/2014CA2656239C Composition and methods for the enterosorption and management of toxins
06/10/2014CA2654334C Antitumoral dihydropyran-2-one compounds
06/10/2014CA2557857C Cancer treatment with topoisomerase-ii inhibitor, a bis-dioxypiperazine and radiation
06/10/2014CA2554683C Use of alkaline phosphatase for the detoxification of lps present at mucosal barriers
06/10/2014CA2530037C Podophyllotoxin derivatives
06/10/2014CA2482634C Diagnostic and therapeutic use of kremen 1 and 2, inhibitors of the canonical wnt-signal transduction
06/10/2014CA2457322C Process for the maturation of dentritic cells and a vaccine
06/05/2014WO2014085791A2 Compositions and uses thereof for treating multiple myeloma
06/05/2014WO2014085698A1 Compositions and methods for the treatment of cancers associated with a deficiency in the mre11/rad50/nbs1 dna damage repair complex
06/05/2014WO2014085666A1 Methods of characterizing and treating molecular subset of muscle-invasive bladder cancer
06/05/2014WO2014085652A1 Targeting cancer with metabolic therapy and hyperbaric oxygen
06/05/2014WO2014085633A1 Substituted biaryl sulfonamides and the use thereof
06/05/2014WO2014085613A1 Hydroxytyrosol and oleuropein compositions for induction of dna damage, cell death and lsd1 inhibition
06/05/2014WO2014085607A1 Substituted 2,3-dihydrobenzofuranyl compounds and uses thereof
06/05/2014WO2014085546A1 Use of ar-42 enhances e7-specific cd8+ t-cell mediated antitumor immunity in conjunction with dna vaccine
06/05/2014WO2014085528A1 Azaquinazoline carboxamide derivatives
06/05/2014WO2014085489A1 Inhibitor of apoptosis protein (iap) antagonists
06/05/2014WO2014085485A1 Methods and compositions for targeting cancer stem cells
06/05/2014WO2014085474A1 Treatment of pulmonary disease
06/05/2014WO2014085471A1 Acid-activated compositions for the treatment of cancers, methods of their use and methods of their preparation
06/05/2014WO2014085461A1 Photodynamic dhsip anticancer therapeutic and immunomodulator
06/05/2014WO2014085437A2 Use of post-transplant cyclophosphamide treated allogeneic marrow infiltrating lymphocytes to augment anti-tumor immunity
06/05/2014WO2014085381A1 Pharmaceutical combinations
06/05/2014WO2014085373A1 Combination
06/05/2014WO2014085371A1 Novel pharmaceutical composition
06/05/2014WO2014085318A1 Combination therapy
06/05/2014WO2014085225A1 Pyrimidine compounds for the treatment of cancer
06/05/2014WO2014084778A1 Pyrimidine-2,4-diamine derivatives for treatment of cancer
06/05/2014WO2014084651A1 A stabilized pemetrexed formulation
06/05/2014WO2014084530A1 Biodegradable microbead comprising anionic polymer for improving adsorptive power to anticancer drugs, and method for preparing same
06/05/2014WO2014084494A1 Novel disubstituted adamantyl derivative or pharmaceutically acceptable salt thereof, production method for same, and pharmaceutical composition for suppressing cancer metastasis comprising same as active ingredient
06/05/2014WO2014084430A1 Combination anti-cancer therapy
06/05/2014WO2014084378A1 Anticancer drug comprising cyclic rgd sequence-containing peptide
06/05/2014WO2014084298A1 Lsd1-selective inhibitor having lysine structure
06/05/2014WO2014084027A1 Medical uses of cell membrane-permeable fibroblast growth factor
06/05/2014WO2014083567A2 Methods of preventing tumor metastasis, treating and prognosing cancer and identifying agents which are putative metastasis inhibitors
06/05/2014WO2014083529A1 Heterocyclic compounds as inhibitors of the sodium iodide symporter
06/05/2014WO2014083095A1 Combinations of metformin with other compounds for the treatment of cancer and for immunosuppression
06/05/2014WO2014083058A1 Combination therapy with volasertib
06/05/2014WO2014083006A1 RECOMBINANT HUMAN IgM-ANTIBODY EFFECTIVE AGAINST CANCER CELLS
06/05/2014WO2014082889A1 Novel imidazolines as dual inhibitors of mdm2 and mdmx
06/05/2014WO2014082598A1 Inhibitors of bruton's tyrosine kinase
06/05/2014WO2014082581A1 Α-(3,5-dimethoxy benzylidene)-α'-hydrocarbyl methylene cyclic ketone and preparation method thereof
06/05/2014WO2014082578A1 Heteroaryl alkyne compound and application thereof
06/05/2014WO2014082570A1 Artemether-containing pharmaceutical composition, preparation, and use thereof
06/05/2014WO2014082569A1 Use of artemether in preparation of drug for treating leukemia
06/05/2014WO2014082354A1 Crystal form of chidamide, preparation method and use thereof
06/05/2014WO2014082286A1 Rafamycin analogs and methods for making same
06/05/2014WO2014082230A1 Pyrrolotriazine derivative, preparation method thereof and application thereof in medicine
06/05/2014WO2014082163A1 Tox inhibition for the treatment of cancer
06/05/2014WO2014027355A3 Cytotoxic titanium and vanadium complexes
06/05/2014WO2013154206A9 Anti-fgfr2 antibody
06/05/2014US20140155418 Receptor-Type Kinase Modulators and Methods of Use
06/05/2014US20140155348 Inclusion Compounds of Fumagillol Derivative or its Salt, and Pharmaceutical Compositions Comprising the Same
06/05/2014US20140154772 Inhibitors of human phosphatidylinositol 3-kinase delta
06/05/2014US20140154306 17alfa, 21-dihydroxypregnene esters as antiandrogenic agents
06/05/2014US20140154259 Method for the treatment of inflammatory disorders
06/05/2014US20140154216 Virus strains
06/05/2014US20140154215 Herpes virus strains
06/05/2014DE102012022778A1 Medicine useful for treating cancer, heart attack and tuberculosis, comprises active ingredient e.g. theobromine which is alkaloid obtained from cocoa, lichenin which is antibiotic derived from oats and caffeine obtained from coffee
06/05/2014CA2863243A1 Rafamycin analogs and methods for making same
06/04/2014EP2738255A1 Erap1-derived peptide and use thereof
06/04/2014EP2738176A1 Water soluble camptothecin derivative, pharmaceutical composition and use thereof
06/04/2014EP2738173A1 Heterocyclic compounds as inhibitors of the sodium iodide symporter
06/04/2014EP2738157A1 Auto-magnetic metal salen complex compound
06/04/2014EP2738156A1 9-aminomethyl substituted tetracycline compound
06/04/2014EP2737896A2 umirolimus encapsulated in a liposome or a micelle for the treating cancer
06/04/2014EP2737062A2 Near-infrared light-activated proteins
06/04/2014EP2736928A1 Sur-binding proteins against erbb3
06/04/2014EP2736920A1 Notch pathway signaling inhibitor compound
06/04/2014EP2736904A1 Oxazole and thiazole derivatives as selective protein kinase inhibitors (c-kit)
06/04/2014EP2736902A1 N-(imidazolidin-2-ylidene)quinoline derivatives as modulators of alpha 2 adrenergic receptors
06/04/2014EP2736901A1 Heterocyclyl pyrimidine analogues as jak inhibitors
06/04/2014EP2736896A1 3-oxo-2,3-dihydro-1h-indazole-4-carboxamide derivatives as parp-1 inhibitors
06/04/2014EP2736895A1 2 - (2, 4, 5 - substituted -anilino) pyrimidine derivatives as egfr modulators useful for treating cancer
06/04/2014EP2736887A1 Hydrazide containing nuclear transport modulators and uses thereof
06/04/2014EP2736535A1 Il-12 immunoconjugate
06/04/2014EP2736534A1 Combination therapy for the treatment of cd19+ b-cell malignancies symptoms comprising an anti-cd19 maytansinoid immunoconjugate and rituximab
06/04/2014EP2736527A1 Dendritic cell (dc)-vaccine therapy for pancreatic cancer
06/04/2014EP2736514A1 Alkynyl substituted pyrimidinyl-pyrroles active as kinases inhibitors
06/04/2014EP2736507A1 Basic alpha lipoic acid solution and its uses
06/04/2014EP2736506A2 Monoamine oxidase inhibitors and methods for treatment and diagnosis of prostate cancer
1 ... 45 46 47 48 49 50 51 52 53 54 55 56 57 58 59 60 61 62 63 64 65 ... 2211